Fig. 4

Relationship between MPRGs risk characteristics and clinical variables. (A) Distribution of clinical characteristics (prognosis, gender, grade, grade, etc.) and expression of risk signature genes in TCGA-KIRC patients in high- and low-risk groups; (B) Kaplain-Meier survival curves of patients in TCGA-KIRC high and low risk groups; (C) Accuracy of Mitophagy Risk Score in Predicting Prognosis of TCGA-KIRC Patients by ROC Curve; (D) Distribution of patient clinical characteristics (prognosis, gender, grade, grade, etc.) and expression of risk signature genes in the high- and low-risk groups in the E-MTAB-1980 dataset; (E) Kaplain-Meier survival curves of patients in high and low risk groups in the E-MTAB-1980 dataset; (F) Accuracy of Mitophagy Risk Score in Predicting Prognosis of E-MTAB-1980 Patients by ROC Curve